Abdelnour, Carla
Agosta, Federica
Bozzali, Marco
Fougère, Bertrand
Iwata, Atsushi
Nilforooshan, Ramin
Takada, Leonel T.
Viñuela, Félix
Traber, Martin
Article History
Received: 13 January 2022
Accepted: 27 July 2022
First Online: 13 August 2022
Declarations
:
: Not applicable.
: Not applicable.
: C.A. has received lecture fees paid by a commercial entity (honoraria) in the last 3 years from Zambon, F. Hoffmann-La Roche Ltd, Schwabe Farma Ibérica S.A.U., and Nutricia.F.A. serves as Section Editor of <i>NeuroImage: Clinical</i> and has received compensation for consulting services and/or speaking activities from Philips, Biogen, and F. Hoffmann-La Roche Ltd.M.B. has received compensation for consulting services and/or lecture fees from Biogen and F. Hoffmann-La Roche Ltd.B.F. has received lecture fees paid by a commercial entity (honoraria) in the last 3 years from Pfizer, Biophytis, BMS, Novartis, Bayer, F. Hoffmann-La Roche Ltd, and Biogen.A.I. has received lecture fees/research grants and has been a member of advisory boards for Eisai and Shionogi. He has also received lecture fees from, and has been a member of advisory boards for, Janssen Pharmaceuticals, Chugai-Roche, and Merck Sharp & Dohme. He has also received lecture fees and research grants from Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Company, Ltd., and Ono Pharmaceutical Co., Ltd. He has also received lecture fees from Kyowa Kirin Co., Ltd., and UCB Japan. He has also received research grants from AbbVie, Dainippon Sumitomo, the Japan Agency for Medical Research and Development, and the Japan Society for the Promotion of Science.R.N. has received fees paid by a commercial entity (honoraria) for consultation from Biogen Inc., F. Hoffmann-La Roche Ltd., and Janssen Pharmaceuticals.L.T.T. has received research grant support from the Alzheimer’s Association and the National Institutes of Health. He has also given talks for Sandoz, Torrent Pharmaceuticals Ltd., written texts for Genom, and participated in events for Sandoz and Torrent Pharmaceuticals Ltd.F.V. has no competing interests to disclose.M.T. is a full-time employee of, and owns shares in, F. Hoffmann-La Roche Ltd.